πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6750254

Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions a

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6747055

Water-soluble drugs and methods for their production

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6743626

Artificial salivary gland

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6743797

Methods for treating cardiac arrhythmia

The United States of America Β· Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6743577

Methods of using cyanovirins to inhibit viral infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6737511

Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6737251

Nucleotide and deduced amino acid sequences of tumor gene Int6

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6734014

Methods and compositions for transforming dendritic cells and activating T cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 11 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6730498

Production of functional proteins: balance of shear stress and gravity

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue May 04 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6719978

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6716450

Enhancing protein activity through nanoencapsulation

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713446

Formulation of boronic acid compounds

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713284

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713081

Ocular therapeutic agent delivery devices and methods for making and using such devices

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713066

Production of attenuated respiratory syncytial virus vaccines involving modification of M2

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6709842

DNA encoding a growth factor specific for epithelial cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6710166

41 kDa Cryptosporidium parvum oocyst wall protein

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6706754

Reversed amidines and methods of using for treating, preventing, or inhibiting leishmanias

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6706873

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic meth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6703046

Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for

The United States of America Β· Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6699842

Dominant negative deletion mutants of C-jun and their use in the prevention and treatment

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6699835

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6696064

Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-ba

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired